Authors:
Tsunoda, S
Yamabe, H
Osawa, H
Kaizuka, M
Shirato, K
Okumura, K
Citation: S. Tsunoda et al., Cultured rat glomerular epithelial cells show gene expression and production of transforming growth factor-beta: expression is enhanced by thrombin, NEPH DIAL T, 16(9), 2001, pp. 1776-1782
Authors:
Kano, Y
Akutsu, M
Tsunoda, S
Suzuki, K
Yazawa, Y
Furukawa, Y
Citation: Y. Kano et al., Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro, JPN J CANC, 92(1), 2001, pp. 74-82
Citation: S. Tsunoda et al., Independent anchoring and assembly mechanisms of INAD signaling complexes in Drosophila photoreceptors, J NEUROSC, 21(1), 2001, pp. 150-158
Authors:
Sugikawa, E
Tsunoda, S
Nakanishi, N
Ohashi, M
Citation: E. Sugikawa et al., 9-hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein, ANTICANC R, 21(4A), 2001, pp. 2671-2675
Authors:
Freeman, R
Tsunoda, S
Supran, S
Warshaw, A
Smith, J
Fairchild, R
Pratt, D
Rohrer, R
Citation: R. Freeman et al., Direct costs for one year of liver transplant care are directly associatedwith disease severity at transplant, TRANSPLAN P, 33(1-2), 2001, pp. 1436-1437
Authors:
Hirano, N
Kohno, J
Tsunoda, S
Nishio, M
Kishi, N
Okuda, T
Kawano, K
Komatsubara, S
Nakanishi, N
Citation: N. Hirano et al., TMC-69, a new antitumor antibiotic with Cdc25A inhibitory activity, produced by Chrysosporium sp TC1068 - Taxonomy, fermentation and biological activities, J ANTIBIOT, 54(5), 2001, pp. 421-427
Authors:
Tsunoda, S
Ishikawa, T
Watanabe, M
Kamada, H
Yamamoto, Y
Tsutsumi, Y
Hirano, T
Mayumi, T
Citation: S. Tsunoda et al., Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino-protective reagent, BR J HAEM, 112(1), 2001, pp. 181-188
Authors:
Kano, Y
Akutsu, M
Tsunoda, S
Mano, H
Sato, Y
Honma, Y
Furukawa, Y
Citation: Y. Kano et al., In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents, BLOOD, 97(7), 2001, pp. 1999-2007
Authors:
Nagaoka, S
Inoue, M
Nishioka, C
Nishioku, Y
Tsunoda, S
Ohguchi, C
Ohara, K
Mukai, K
Nagashima, U
Citation: S. Nagaoka et al., Tunneling effect in antioxidant, prooxidant, and regeneration reactions ofvitamin E, J PHYS CH B, 104(4), 2000, pp. 856-862
Authors:
Yamabe, H
Osawa, H
Kaizuka, M
Tamura, N
Tsunoda, S
Shirato, K
Tateyama, F
Okumura, K
Citation: H. Yamabe et al., Angiotensin II further enhances type IV collagen production stimulated by platelet-derived growth factor and fibroblast growth factor-2 in cultured human mesangial cells, NEPHROLOGY, 5(4), 2000, pp. 225-229
Authors:
Kano, Y
Akutsu, M
Suzuki, K
Yazawa, Y
Tsunoda, S
Furukawa, Y
Citation: Y. Kano et al., Schedule-dependent interaction between raltitrexed and 5-fluorouracil in human colon cancer cell lines in vitro, ONCOL RES, 12(3), 2000, pp. 137-148
Authors:
Yamabe, H
Osawa, H
Kaizuka, M
Tsunoda, S
Shirato, K
Tateyama, F
Okumura, K
Citation: H. Yamabe et al., Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-beta-dependent mechanism, NEPH DIAL T, 15(6), 2000, pp. 872-876
Authors:
Kano, Y
Akutsu, M
Suzuki, K
Yazawa, Y
Tsunoda, S
Citation: Y. Kano et al., Schedule-dependent interactions between raltitrexed and cisplatin in humancarcinoma cell lines in vitro, JPN J CANC, 91(4), 2000, pp. 424-432
Authors:
Wakai, Y
Matsui, J
Koizumi, K
Tsunoda, S
Makimoto, H
Ohizumi, I
Taniguchi, K
Kaiho, S
Saito, H
Utoguchi, N
Tsutsumi, Y
Nakagawa, S
Ohsugi, Y
Mayumi, T
Citation: Y. Wakai et al., Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23), JPN J CANC, 91(12), 2000, pp. 1319-1325
Authors:
Kuroda, K
Miyata, K
Tsutsumi, Y
Tsunoda, S
Nishimura, K
Mitsuishi, Y
Nakagawa, S
Mayumi, T
Citation: K. Kuroda et al., Preferential activity of wild-type and mutant tumor necrosis factor-alpha against tumor-derived endothelial-like cells, JPN J CANC, 91(1), 2000, pp. 59-67
Authors:
Kano, Y
Akutsu, M
Tsunoda, S
Suzuki, K
Ichikawa, A
Furukawa, Y
Bai, L
Kon, K
Citation: Y. Kano et al., In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis, LEUKEMIA, 14(3), 2000, pp. 379-388
Authors:
Tsunoda, S
Kawano, M
Koni, I
Kasahara, Y
Yachie, A
Miyawaki, T
Seki, H
Citation: S. Tsunoda et al., Diminished expression of CD59 on activated CD8(+) T cells undergoing apoptosis in systemic lupus erythematosus and Sjogren's syndrome, SC J IMMUN, 51(3), 2000, pp. 293-299
Authors:
Tsunoda, S
Kamada, H
Yamamoto, Y
Ishikawa, T
Matsui, J
Koizumi, K
Kaneda, Y
Tsutsumi, Y
Ohsugi, Y
Hirano, T
Mayumi, T
Citation: S. Tsunoda et al., Molecular design of polyvinylpyrrolidone-conjugated interleukin-6 for enhancement of in vivo thrombopoietic activity in mice, J CONTR REL, 68(3), 2000, pp. 335-341
Authors:
Nakamura, M
Konishi, N
Tsunoda, S
Nakase, H
Tsuzuki, T
Aoki, H
Sakitani, H
Inui, T
Sakaki, T
Citation: M. Nakamura et al., Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults, ONCOL-BASEL, 58(2), 2000, pp. 108-116
Authors:
Osawa, H
Yamabe, H
Kaizuka, M
Tamura, N
Tsunoda, S
Baba, Y
Shirato, K
Tateyama, F
Okumura, K
Citation: H. Osawa et al., C-type natriuretic peptide inhibits proliferation and monocyte chemoattractant protein-1 secretion in cultured human mesangial cells, NEPHRON, 86(4), 2000, pp. 467-472
Authors:
Kamada, H
Tsutsumi, Y
Yamamoto, Y
Kihira, T
Kaneda, Y
Mu, Y
Kodaira, H
Tsunoda, S
Nakagawa, S
Mayumi, T
Citation: H. Kamada et al., Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice, CANCER RES, 60(22), 2000, pp. 6416-6420